Figure 6.
Levels of inflammatory factors in the plasma of pregnant rats in each group at the end of pregnancy (GD20) were measured using the BioLegend multi-factor flow assay. (A) Circulating MCP-1, (B) IL-17A, (C) TNF-α and (D) IL-1β levels. **P<0.05 vs. control group. Values are expressed as the mean ± standard deviation. Groups: 9D LL, rats treated with low-dose L-NAME (40 mg/kg body weight/day) starting from GD 9; 9D ML, rats treated with medium-L-NAME (75 mg/kg body weight/day) starting from GD 9; 9D HL, rats treated with high-dose L-NAME (125 mg/kg body weight/day) starting from GD 9; 10D LL, rats treated with low-dose L-NAME (40 mg/kg body weight/day) starting from GD 10; 10D ML, rats treated with medium-L-NAME (75 mg/kg body weight/day) starting from GD 10; 10D HL, rats treated with high-dose L-NAME (125 mg/kg body weight/day) starting from GD 10; control, normal pregnancy group. GD, gestational day; L-NAME, N-nitro-L-arginine methyl ester; TNF, tumor necrosis factor; IL, interleukin; MCP, monocyte chemoattractant protein.
